Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vitae Pharmaceuticals, Inc (VTAE)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-15Dec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K10-K
Net income  -44.0-19.11.20.2
Depreciation and amortization  0.20.20.20.5
Stock-based compensation  2.42.20.10.3
Change in working capital   [+]20.3-1.110.7-10.8
Other operating activities  -16.9-0.10.00.0
Cash from operations  -38.0-17.812.1-9.8
   
Capital expenditures   [+]-0.3-0.3-0.2-0.1
Purchases of short-term investments, net  -11.8-24.65.9-3.4
Cash from investing  -12.1-24.85.7-3.5
   
Issuance of common stock, net  39.858.90.10.0
Financing costs     0.0
Other cash from financing  -7.5-7.9-4.40.0
Cash from financing  32.451.0-4.30.0
   
Free cash flow  -38.3-18.111.9-10.0
        Per share (diluted)  ($1.77)($3.42)$21.22($18.38)
   
Cash paid for interest  0.40.71.21.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy